Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients

Liver International

Volumn 29, Issue 5, 2009, Pages 702-707

  Miyaaki, Hisamitsu ^a   Zhou, Huijuan ^a,b   Ichikawa, Tatsuki ^a   Nakao, Kazuhiko ^a   Shibata, Hidetaka ^a   Takeshita, Shigeyuki ^a   Akiyama, Motohisa ^a   Ozawa, Eisuke ^a   Miuma, Satoshi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Foxp3; Hepatitis B virus; Hepatitis C virus; Regulatory T cell

Indexed keywords

ALANINE AMINOTRANSFERASE; CD56 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NEEDLE BIOPSY; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; TARGET ORGAN; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B; HEPATITIS C; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY;

EID: 64749102802     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01842.x     Document Type: Article

References (30)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathology. Springer Semin Immunopathol 1995; 17: 261-8.
2. European Association for the Study of the Liver. International consensus conference on hepatitis C. Paris, 26-28 February 1999. J Hepatol 1999; 30: 956-61.
3. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-62.
4. Piccirillo CA, Thornton AM. Cornerstone of peripheral tolerance: naturally occurring CD4+ CD25+ regulatory T cells. Trends Immunol 2004; 25: 374-80.
5. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114: 1198-20.
6. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
7. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-22.
8. Hori S, Sakaguchi S. Foxp3: A critical regulator of the development and function of regulatory T cells. Microbes Infect 2004; 6: 745-51.
9. Coutinho A, Hori S, Carvalho T, et al. Regulatory T cells: The physiology of autoreactivity in dominant tolerance and "quality control" of immune responses. Immunol Rev 2001; 182: 89-98.
10. Lan RY, Ansari AA, Lian ZX, et al. Regulatory T cells: Development, function and role in autoimmunity. Autoimmun Rev 2005; 4: 351-63.
11. Furuno K, Yuge T, Kusuhara K, et al. CD25+ CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 2004; 145: 385-90.
12. Kukreja A, Cost G, Marker J, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-40.
13. Shevach EM, Piccirillo CA, Thornton AM, et al. Control of T cell activation by CD4+ CD25+ suppressor T cells. Novartis Found Symp 2003; 252: 24-36; discussion 36-44, 106-114.
14. Kim JD, Choi BK, Bae JS, et al. Cloning and characterization of GITR ligand. Genes Immun 2003; 4: 564-9.
15. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-52.
16. Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 2004; 114: 1209-17.
17. Gondek DC, Lu LF, Quezada SA, et al. Cutting edge: Contact-mediated suppression by CD4+ CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174: 1783-6.
18. Andersson J, Boasso AC, Nilssonc J, et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005; 174: 3143-7.
19. Stoop JN, Van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-8.
20. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-47.
21. Cao D, Malmstrom V, Baecher-Allan C, et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-23.
22. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+ CD25- T cells. J Clin Invest 2003; 112: 1437-43.
23. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198: 235-47.
24. Reddy J, Waldner H, Zhang X, et al. Cutting edge: CD4+ CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol 2005; 175: 5591-5.
25. Benten WP, Becker A, Schmitt-Wrede HP, et al. Developmental regulation of intracellular and surface androgen receptors in T cells. Steroids 2002; 67: 925-31.
26. Sakazaki H, Ueno H, Nakamuro K. Estrogen receptor alpha in mouse splenic lymphocytes: Possible involvement in immunity. Toxicol Lett 2002; 133: 221-9.
27. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131: 470-7.
28. Mangia A, Ricci GL, Persico M, et al. A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naive patients with chronic hepatitis C. J Viral Hepat 2005; 12: 292-9.
29. Xie Y, Xu DZ, Lu ZM, et al. Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: A randomized, open, and multi-center controlled trial. Hepatobiliary Pancreat Dis Int 2005; 4: 213-9.
30. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170: 1304-12.